ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

BSML Invesco BulletShares 2021 Municipal Bond

25.195
0.00 (0.00%)
28 Jun 2024 - Closed
Delayed by 15 minutes
Name Symbol Market Type
Invesco BulletShares 2021 Municipal Bond NASDAQ:BSML NASDAQ Exchange Traded Fund
  Price Change % Change Price Bid Price Offer Price High Price Low Price Open Price Traded Last Trade
  0.00 0.00% 25.195 19.77 27.52 0 01:00:00

Dr. Julian Feneley Appointed CEO of BSML, Inc., Formerly BriteSmile, Inc.

03/11/2006 6:46pm

PR Newswire (US)


Invesco BulletShares 202... (NASDAQ:BSML)
Historical Stock Chart


From Jun 2019 to Jun 2024

Click Here for more Invesco BulletShares 202... Charts.
John Reed, Current CEO, to Leave the Company November 15, 2006 WALNUT CREEK, Calif., Nov. 3 /PRNewswire-FirstCall/ -- BSML, Inc., formerly known as BriteSmile, Inc., (NasdaqSC: BSML) today announced that its CEO and President, John Reed, will leave the Company on November 15, 2006. Dr. Julian Feneley, a current director of the Company who previously served as its President, will re-join the Company on November 15, 2006 as its CEO and President. Anthony M. Pilaro, the Chairman of the Board of Directors of the Company said, "We are extremely fortunate that Dr. Julian Feneley is returning to the Company as its CEO and President, under the terms of a five year employment agreement." Mr. Pilaro continued, "We are also extremely grateful for the extraordinary effort John has given to managing the Company since the sale of the Associated Centers business." Dr. Feneley began working with BriteSmile as a consultant in January 2002, focusing on strategic and development initiatives, and was appointed President of the Company in February 2004. Previously, Dr Feneley co-founded narrowbridge (e-customer acquisition technology company) and Bioscience Managers (biotechnology venture capital and corporate finance boutique). Until 2000, Dr. Feneley headed the European healthcare investment banking franchise of J P Morgan. Prior to joining J P Morgan in 1990, Dr. Feneley qualified and worked as a medical doctor at the renowned Guy's Hospital in London, England. BSML, Inc., formerly known as BriteSmile, Inc., has developed and markets the most advanced teeth whitening technology available, as well as manages state-of-the-art BriteSmile Professional Teeth Whitening Centers. BSML Spa Centers are currently operating in Beverly Hills, Irvine, Palo Alto, Walnut Creek, San Francisco and La Jolla, CA; Houston, TX; Denver, CO; Boston, MA; McLean, VA; Atlanta, GA; New York, NY; Chicago and Schaumburg, IL; and, Phoenix, AZ. For more information about BSML's procedures, call 1-800-BRITESMILE or visit the Company's Website at http://www.britesmile.com/ . This release, other than historical information, consists of forward- looking statements that involve risks and uncertainties. Readers are referred to the documents filed by BSML with the Securities and Exchange Commission, specifically the Company's most recent reports on Forms 10-K and 10-Q, that identify important risk factors which could cause actual results to differ from those contained in the forward-looking statements. BSML and its affiliates disclaim any intent or obligation to update these forward-looking statements. DATASOURCE: BSML, Inc. CONTACT: Kenneth A. Czaja, CFO, +1-925-941-6260, or Philip Powell, +1-925-279-2863 Web site: http://www.britesmile.com/

Copyright

1 Year Invesco BulletShares 202... Chart

1 Year Invesco BulletShares 202... Chart

1 Month Invesco BulletShares 202... Chart

1 Month Invesco BulletShares 202... Chart

Your Recent History

Delayed Upgrade Clock